Clinical Model Could Guide GBA Gene Testing in Parkinson's

Applying a simple model of clinical and demographic features associated with GBA mutation carrier status could help target genetic testing in patients with Parkinson's disease, suggests a new study.

Related Keywords

Florida ,United States ,New York ,Copenhagen ,Køavn ,Denmark ,Gainesville ,University Of Florida ,Michaels Okun ,Julia Greenberg ,Movement Disorders ,Langone Health ,Norman Fixel Institute For Neurological Diseases ,International Congress ,Parkinson Progression Markers Initiative ,University Of Florida Health ,Specific Population ,Medscape Medical News ,Ashkenazi Jewish ,Progression Markers Initiative ,Step Toward ,More Sensitive ,Norman Fixel Institute ,Neurological Diseases ,Florida Health ,Medscape Medical ,Parkinsons Disease ,Genetic Testing ,Genetics ,Genomics ,Genomic Medicine ,Edicine Genomic ,Cognitive Impairment ,Preventive Screening ,Screening ,Physician Patient Decision Making ,Patient Counseling ,Rovider Patient Communication ,Linician Patient Relationship Counseling ,Hysician Patient Collaboration ,Patient Preferences ,Patient Centered Care ,Partners In Care ,Are Planning ,Activate ,Zempow ,